Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency
Danilo Fintini, Claudia Brufani, Marco CappaEndocrinology Unit, “Bambino Gesù” Children’s Hospital-IRCCS, Rome, ItalyAbstract: Growth hormone insensitivity syndrome (GHI) or insulin-like growth factor-1 (IGF-1) deficiency (IGFD) is characterized by deficit of...
Saved in:
Main Authors: | Danilo Fintini (Author), Claudia Brufani (Author), Marco Cappa (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia ( Deficiency)
by: Bradley S. Miller MD, PhD, et al.
Published: (2013) -
Clinical characteristics and treatment efficacy in patients with primary severe IGF-1 deficiency treated with recombinant IGF-1
by: Dovile Denaite, et al.
Published: (2024) -
Perianastomotic ulceration presenting with long-term iron deficiency anemia and growth failure: A case report and review of the literature
by: Kyung Ji Kang, et al.
Published: (2010) -
Chronic Kidney Disease and Growth Failure in Children
by: Tommaso Todisco, et al.
Published: (2024) -
A Proposal for the Interpretation of Serum IGF-I Concentration as Part of Laboratory Screening in Children with Growth Failure
by: Jan M. Wit, et al.
Published: (2020)